Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 02, 2024

BUY
$161.01 - $317.85 $301,410 - $595,015
1,872 Added 9.93%
20,720 $6.56 Million
Q2 2023

Aug 02, 2023

BUY
$176.32 - $240.22 $296,041 - $403,329
1,679 Added 9.78%
18,848 $4.09 Million
Q3 2022

Oct 28, 2022

SELL
$123.79 - $277.42 $564,977 - $1.27 Million
-4,564 Reduced 21.0%
17,169 $3.86 Million
Q2 2022

Aug 04, 2022

SELL
$93.97 - $143.33 $155,614 - $237,354
-1,656 Reduced 7.08%
21,733 $2.75 Million
Q1 2022

May 03, 2022

BUY
$98.9 - $132.37 $215,503 - $288,434
2,179 Added 10.27%
23,389 $2.97 Million
Q4 2021

Jan 31, 2022

SELL
$110.64 - $159.4 $531,735 - $766,076
-4,806 Reduced 18.47%
21,210 $2.78 Million
Q3 2021

Oct 27, 2021

BUY
$101.2 - $125.87 $414,818 - $515,941
4,099 Added 18.7%
26,016 $3.18 Million
Q2 2021

Jul 23, 2021

BUY
$107.45 - $135.95 $2.35 Million - $2.98 Million
21,917 New
21,917 $2.5 Million

Others Institutions Holding KRTX

About Karuna Therapeutics, Inc.


  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track State Of New Jersey Common Pension Fund D Portfolio

Follow State Of New Jersey Common Pension Fund D and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of New Jersey Common Pension Fund D, based on Form 13F filings with the SEC.

News

Stay updated on State Of New Jersey Common Pension Fund D with notifications on news.